These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 6334177)
21. Toxicological studies on a new macrolide antibiotic, midecamycin acetate (miokamycin). Part II-1. Subacute toxicity in rats. Yokota M; Takeda U; Odaki M; Sasaki H; Niizato T; Kawaoto H; Watanabe H; Ishiwatari N; Koeda T Jpn J Antibiot; 1984 Jul; 37(7):1321-32. PubMed ID: 6333528 [TBL] [Abstract][Full Text] [Related]
22. Toxicological studies on a new macrolide antibiotic, midecamycin acetate (miokamycin). Part III-1. Chronic toxicity in rats. Yokota M; Takeda U; Odaki M; Sasaki H; Niizato T; Kawaoto H; Watanabe H; Itoh T; Ishiwatari N; Koeda T Jpn J Antibiot; 1984 Jul; 37(7):1355-75. PubMed ID: 6333530 [TBL] [Abstract][Full Text] [Related]
23. Effects of midecamycin acetate (miocamycin), a new macrolide antibiotic, on reproductive performances in rats and rabbits. Moriguchi M; Takeda U; Hata T; Yamamoto A; Koeda T Jpn J Antibiot; 1984 Aug; 37(8):1572-95. PubMed ID: 6334185 [TBL] [Abstract][Full Text] [Related]
24. Radioimmunoassay for metabolites of 9,3"-diacetylmidecamycin, a macrolide antibiotic. Shimada N; Ueda T; Yokoshima T; Umemura K; Shomura T Antimicrob Agents Chemother; 1982 Dec; 22(6):976-80. PubMed ID: 6984320 [TBL] [Abstract][Full Text] [Related]
25. [Clinical studies on 9, 3"-diacetylmidecamycin in respiratory tract infections in the field of pediatrics (author's transl)]. Iwai N; Sasaki A; Taneda Y; Mizoguchi F; Nakamura H Jpn J Antibiot; 1982 Mar; 35(3):739-53. PubMed ID: 6285015 [TBL] [Abstract][Full Text] [Related]
26. [Pharmacokinetics of ponsinomycin administered in a syrup form in single 400-800 and 1200 mg doses in healthy volunteers]. Couet W; Girault J; Reigner B; Ingrand I; Bizouard J; Fourtillan JB Pathol Biol (Paris); 1989 May; 37(5):428-32. PubMed ID: 2789363 [TBL] [Abstract][Full Text] [Related]
27. In vitro and in vivo antibacterial activity of 9,3"-Di-o-acetyl midecamycin (Mom), a new macrolide antibiotic. Kawaharajo K; Sekizawa Y; Inoue M J Antibiot (Tokyo); 1981 Apr; 34(4):436-42. PubMed ID: 6974163 [TBL] [Abstract][Full Text] [Related]
28. Toxicological studies on the new veterinary antibiotic turimycin. Härtl A; Hoffmann H Pol J Pharmacol Pharm; 1980; 32(2):217-24. PubMed ID: 7454626 [TBL] [Abstract][Full Text] [Related]
29. [Clinical use and evaluation of 9,3"-di-0-acetyl midecamycin (MOM) in oral surgery]. Satoh T; Sugiura Y; Fujiwara H; Suzuki M; Takahashi K; Saigusa F; Nishida K; Hisano Y Shigaku; 1982 Jun; 70(1):126-36. PubMed ID: 6985345 [No Abstract] [Full Text] [Related]
31. Activities of human alveolar macrophages (HAMs). Note 1: Observations on phagocytosis and bacterial killing in the presence of miocamycin. Capelli A; Capelli O; Azzolini L; Richeldi L; Prandi E; Velluti G Chemioterapia; 1988 Apr; 7(2):89-95. PubMed ID: 3260827 [TBL] [Abstract][Full Text] [Related]
32. [Studies on concentrations in body fluids of 16-membered ring macrolide antibiotics upon oral administration to healthy volunteers. Effects of their metabolites on bioassay values]. Suzuki T; Sakai A; Morishita M; Ishioka T; Shimizu K Jpn J Antibiot; 1988 May; 41(5):510-22. PubMed ID: 3216473 [TBL] [Abstract][Full Text] [Related]
33. Synergistic effects of a macrolide and a cell wall-affecting antibiotic on Pseudomonas aeruginosa in vitro and in vivo. 1. Combined effects of a macrolide and a peptide antibiotic. Kasai T; Homma JY J Antibiot (Tokyo); 1982 Mar; 35(3):343-8. PubMed ID: 6281226 [TBL] [Abstract][Full Text] [Related]
34. [General pharmacological studies on a new macrolide antibiotic, miokamycin (MOM). 1. Effects on the central nervous system (author's transl)]. Shibata U; Yamaki Y; Asaoka H; Sugiyama S; Takeda U; Nishimori T; Kobayashi F; Hori K Jpn J Antibiot; 1981 May; 34(5):734-46. PubMed ID: 6974788 [TBL] [Abstract][Full Text] [Related]
35. Acyl derivatives of 16-membered macrolides. I. Synthesis and biological properties of 3"-O-propionylleucomycin A5 (TMS-19-Q). Sakakibara H; Okekawa O; Fujiwara T; Otani M; Omura S J Antibiot (Tokyo); 1981 Aug; 34(8):1001-10. PubMed ID: 7319915 [TBL] [Abstract][Full Text] [Related]
36. Bacteriological evaluation of midecamycin acetate and its metabolites. Yoshida T; Watanabe T; Shomura T; Someya S; Okamoto R; Ishihara S; Miyauchi K; Kazuno Y Jpn J Antibiot; 1982 Jun; 35(6):1462-74. PubMed ID: 6982352 [TBL] [Abstract][Full Text] [Related]
37. [Tissue distribution of 9, 3"-diacetylmidecamycin in the pregnant rat and in the rat following repeated administration (author's transl)]. Someya S; Shomura T; Murata S Jpn J Antibiot; 1982 Mar; 35(3):761-5. PubMed ID: 6980293 [TBL] [Abstract][Full Text] [Related]
38. [Microbiological, pharmacokinetic and clinical studies of rokitamycin dry syrup in the pediatric field]. Motohiro T; Aramaki M; Oda K; Kawakami A; Tanaka K; Koga T; Fujimoto T; Sakata Y; Yamashita F; Suzuki K Jpn J Antibiot; 1988 Jul; 41(7):920-59. PubMed ID: 3050186 [TBL] [Abstract][Full Text] [Related]
39. [Experience with the use of 9,3"-diacetylmidecamycin dry syrup in pediatrics]. Kobayashi Y; Haruta T; Kuroki S; Ohkura K Jpn J Antibiot; 1982 May; 35(5):1207-11. PubMed ID: 6982351 [TBL] [Abstract][Full Text] [Related]
40. [Clinical study on 9,3"-diacetylmidecamycin in the field of pediatrics (author's transl)]. Minamitani M; Hachimori K; Suzuki M Jpn J Antibiot; 1982 Apr; 35(4):909-18. PubMed ID: 6980295 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]